Operations Excellence: Managing Your Suppliers for Maximum Results - After achieving performance successes within your organization, where should you look next? - BioPharm International

ADVERTISEMENT

Operations Excellence: Managing Your Suppliers for Maximum Results
After achieving performance successes within your organization, where should you look next?


BioPharm International
Volume 19, Issue 9

Better supplier management doesn't need to wait for the Operations Excellence program to mature in production. Many of the above identified improvements can begin in parallel to production-related improvements.

However, companies need to face reality: The biopharm industry will not likely reach the production volumes of small molecule producers or companies in other industries for years to come. Until better leverage is achieved, your company will need to put in extra effort and management to minimize supplier risk to quality and delivery.

CONSORTIUM UPDATE

The latest East Coast consortium meeting was held August 22 at Human Genome Sciences in Rockville, MD. The meeting was well attended and focused on the challenges of moving a new plant from qualification to commercial development. The session included a tour of the new large scale facility. The next European Consortium is scheduled for September 26 at Avecia in the UK. Go to http://www.tefen.com/bio for information on past and future meetings.

Marc Puich is a partner at Tefen, Ltd., 1065 E. Hillsdale Blvd., Suite 421, Foster City, CA, 94404; Tel 650.357.1120 x117, Fax 650.372.1350,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here